🔗 Share this article

Treasury head Rachel Reeves has revealed she is preparing "focused measures to address cost of living challenges" in the upcoming financial statement.

During an interview with the BBC, she emphasized that reducing price rises is a collective task of both the administration and the Bank of England.

The United Kingdom's inflation rate is projected to be the most elevated among the G7 industrialized countries this year and next.

Potential Utility Bill Interventions

Sources suggest the administration could take action to lower energy bills, for example by cutting the present 5% level of VAT charged on energy.

Another option is to reduce some of the regulatory levies presently included in bills.

Fiscal Limitations and Analyst Predictions

The administration will obtain the next draft from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will show how much space there is for such measures.

The expectation from most economists is that Reeves will have to declare tax increases or budget cuts in order to fulfill her declared fiscal targets.

Previously on the same day, estimates suggested there was a £22 billion gap for the chancellor to fill, which is at the more modest range of expectations.

"It is a shared responsibility between the Bank of England and the government to further reduce some of the sources of price increases," Reeves stated to reporters in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Pledges and International Issues

While a great deal of the attention has been on expected tax increases, the chancellor said the latest information from the fiscal watchdog had not changed her commitment to campaign commitments not to raise tax levels on earnings tax, VAT or social security contributions.

She attributed an "uncertain world" with increasing international and commercial tensions for the Budget tax moves, likely to be targeted on those "wealthiest."

International Trade Tensions

Referring to worries about the UK's commercial links with the Asian nation she said: "The UK's security interests always are paramount."

Last week's announcement by Chinese authorities to strengthen trade restrictions on rare earths and other resources that are crucial for high-technology production led American leader Donald Trump to threaten an extra 100% tariff on imports from the Asian country, raising the risk of an all-out commercial conflict between the two largest economies.

The US Treasury Secretary labeled the Chinese decision "commercial pressure" and "a international production power grab."

Questioned on accepting the US offer to participate in its conflict with China, the Chancellor said she was "very concerned" by China's measures and urged the Beijing authorities "not to put up barriers and limit trade."

She said the action was "harmful for the global economy and causes additional challenges."

"I believe there are fields where we must address Chinese policies, but there are also important chances to export to China's economy, including financial services and other sectors of the economy. We've got to get that equilibrium appropriate."

The chancellor also confirmed she was collaborating with international partners "on our own essential resources approach, so that we are less reliant."

NHS Medicine Pricing and Funding

The Chancellor also admitted that the cost the National Health Service spends on medicines could rise as a result of current discussions with the US government and its drugs companies, in exchange for reduced taxes and capital.

A number of the world's largest drug companies have said in recent statements that they are either pausing or abandoning operations in the United Kingdom, with some attributing the insufficient payments they are getting.

Recently, the Science Minister said the cost the health service spends on medicines would need to rise to stop businesses and pharmaceutical investment leaving the UK.

The Chancellor told media: "It has been observed as a result of the payment system, that medical research, recent pharmaceuticals have not been offered in the UK in the manner that they are in other continental states."

"We want to guarantee that individuals getting treatment from the NHS are can receive the finest critical drugs in the world. And so we are reviewing all of that, and... looking to obtain additional funding into Britain."